Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VIRS vs. MSOS: which is better?

Bottom line

VIRS vs MSOS: the short answer

VIRS (Pacer BioThreat Strategy ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.

Updated Nov 19, 2026

VIRS vs MSOS side by side

VIRSMSOS
TypeETFETF
Fund familyPacerAdvisorshares
CategoryOtherOther
Expense ratio—0.78%
Annual cost per $10k—$78
10-yr cost on $10k (prospectus)—$927
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+23.4%
5-yr return (annualized)—−33.6%
10-yr return (annualized)——
Best quarter—+102.2%
Worst quarter—−50.4%
Net assets (fund)—$1.0B
Number of holdings—61
Portfolio turnover—5%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

VIRS and MSOS share none of their top holdings.

VIRS top 10

    MSOS top 10

    1. Curaleaf Holdings Inc — 12.32%
    2. Trulieve Cannabis Corp — 9.56%
    3. Blackrock Treasury Trust — 5.78%
    4. Terrascend Corp — 2.70%
    5. Marex Capital Markets Inc. — 2.16%
    6. Cantor Fitzgerald & Co. — 1.08%
    7. Morgan Stanley & Co. Llc — 0.94%
    8. Glass House Brands Inc — 0.93%
    9. Nomura Securities International, Inc. — 0.85%
    10. Cantor Fitzgerald & Co. — 0.78%

    FAQ

    What is the difference between VIRS and MSOS?
    VIRS (Pacer BioThreat Strategy ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.
    Should I own both VIRS and MSOS?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.